Description
RevMAb has developed a revolutionary monoclonal antibody generation method that allows the development of monoclonal antibodies without the generation of hybridoma. With the help of RevMAb scientists with over 20 years of experience, this revolutionary method has successfully been applied to develop high-quality specific anti-idiotype antibodies for different applications. Please contact us to get quotes and details.